Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar 28;24(1):144.
doi: 10.1186/s12933-025-02666-z.

Heart rate variability tests for diagnosing cardiovascular autonomic neuropathy in patients with type 2 diabetes mellitus in advanced stages of kidney disease

Affiliations

Heart rate variability tests for diagnosing cardiovascular autonomic neuropathy in patients with type 2 diabetes mellitus in advanced stages of kidney disease

João Soares Felício et al. Cardiovasc Diabetol. .

Abstract

Cardiovascular Autonomic Neuropathy (CAN) is one of the most devastating complications of Diabetes Mellitus (DM) and presents high morbidity and mortality. Its association with diabetic kidney disease (DKD) worsens the condition even further. CAN diagnosis remains a challenge and is being based on reflex tests which are laborious, risky and difficult to perform. Heart Rate Variability (HRV) tests has been suggested as having high utility in diagnosing CAN, but this issue remains controversial. The aim is to evaluate the sensitivity and specificity of HRV tests to diagnose CAN in patients with type 2 diabetes mellitus (T2DM) and DKD with severely increased albuminuria. This is a cross-sectional study in patients with T2DM and DKD with severely increased albuminuria. A total of 48 subjects were recruited and underwent laboratory and neuropathy assessment. The diagnosis of CAN was first confirmed in 75% (36/48) of patients based on cardiovascular autonomic reflex tests (CARTs). HRV tests (VLF, LF, TP and SDNN) differed between groups with and without CAN (212 vs. 522 ms2, p = 0.024; 57 vs. 332 ms2, p = 0.025; 359.5 vs. 2733 ms2, p = 0.007; 20 vs. 48 ms, p = 0.012), respectively. The best cut-off points based on ROC curve were < 1,117 ms2, < 152.5 ms2, < 1,891 ms2 and < 46.5 ms, respectively. VLF and TP reached highest sensitivity values (97% and 92%) and F1 Score of 90%, while LF had best specificity (75%) and TP had best accuracy (85%). Our best model of serial algorithm using VLF as first screening test and TP in sequency obtained a sensitivity of 97% and accuracy of 90%, reducing in 90% the need to perform CARTs. Our findings suggest that it is possible to achieve high sensitivity and accuracy using an algorithm with VLF and TP parameters analyzed in series. It could enable a simpler and early diagnosis, avoiding CARTs complications.

Keywords: Cardiovascular autonomic neuropathy; Diabetic kidney disease; Diagnostic tests; Type 2 diabetes mellitus.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: The studies involving human participants were reviewed and approved by University Hospital João de Barros Barreto ethics committee, in accordance with the national legislation, resolution 466/12 (National Health Council). A written informed consent form to participate in this study was obtained from all patients. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Cut-off points for HRV parameters on the diagnosis of can based on ROC curve. AUC: Area under the ROC curve; 95% IC: confidence interval; J: Youden Index; Sens: Sensitivity; Spec: Specificity; Accu: Accuracy; LR+: Positive Likelihood Ratio; LR -: Negative likelihood ratio; TP = Total power. VLF = Very low frequency; LF = Low frequency; SDNN = Standard deviation from normal RR intervals.
Fig. 2
Fig. 2
Can diagnostic algorithm in patients with T2DM and advanced stages DKD. T2DM: Type 2 diabetes mellitus; DKD: Diabetic kidney disease; EKG: electrocardiogram; VLF = Very low Frequency; TP = Total Power; CAN: Cardiovascular autonomic neuropathy.

References

    1. Rolim LC, Thyssen PJ, Flumignan RL, Andrade DCD, Dib SA, Bertoluci M. Diagnóstico e Tratamento Da neuropatia periférica diabética. Diretriz Oficial Da Sociedade Brasileira De Diabetes. 2022. 10.29327/557753.2022-14. - DOI
    1. Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care. 2003;26:1553–79. - PubMed
    1. Freeman R. Diabetic autonomic neuropathy. Handbook of clinical neurology. Elsevier; 2014. pp. 63–79. - PubMed
    1. American Diabetes Association Professional Practice Committee. 12. Retinopathy, neuropathy, and foot care: standards of care in diabetes-2024. Diabetes Care. 2024;47:S231–43. - PMC - PubMed
    1. Rolim LCDSP, Sá JRD, Chacra AR, Dib SA. Neuropatia autonômica cardiovascular diabética: fatores de Risco, impacto clínico e Diagnóstico precoce. Arq Bras Cardiol. 2008. 10.1590/S0066-782X2008000400014. - DOI - PubMed

MeSH terms

LinkOut - more resources